169 related articles for article (PubMed ID: 10082313)
1. Protective effect of quinaprilat, an active metabolite of quinapril, on Ca2+-overload induced by lysophosphatidylcholine in isolated rat cardiomyocytes.
Ma H; Hashizume H; Hara A; Yazawa K; Abiko Y
Jpn J Pharmacol; 1999 Jan; 79(1):17-24. PubMed ID: 10082313
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of quinaprilat and trandolaprilat, active metabolites of quinapril and trandolapril, on hemolysis induced by lysophosphatidylcholine in human erythrocytes.
Hayase N; Satomi M; Hara A; Awaya T; Shimizu K; Matsubara K
Biol Pharm Bull; 2003 May; 26(5):712-6. PubMed ID: 12736518
[TBL] [Abstract][Full Text] [Related]
3. Effects of beta-adrenoceptor antagonists on Ca(2+)-overload induced by lysophosphatidylcholine in rat isolated cardiomyocytes.
Chen M; Hashizume H; Abiko Y
Br J Pharmacol; 1996 Jun; 118(4):865-70. PubMed ID: 8799555
[TBL] [Abstract][Full Text] [Related]
4. Effects of ACE inhibitors on circulating versus cardiac angiotensin II in volume overload-induced cardiac hypertrophy in rats.
Ruzicka M; Skarda V; Leenen FH
Circulation; 1995 Dec; 92(12):3568-73. PubMed ID: 8521580
[TBL] [Abstract][Full Text] [Related]
5. Competitive inhibition of glycylsarcosine transport by enalapril in rabbit renal brush border membrane vesicles: interaction of ACE inhibitors with high-affinity H+/peptide symporter.
Lin CJ; Akarawut W; Smith DE
Pharm Res; 1999 May; 16(5):609-15. PubMed ID: 10350000
[TBL] [Abstract][Full Text] [Related]
6. ACE inhibitors and cardiac ACE mRNA in volume overload-induced cardiac hypertrophy.
Lear W; Ruzicka M; Leenen FH
Am J Physiol; 1997 Aug; 273(2 Pt 2):H641-6. PubMed ID: 9277479
[TBL] [Abstract][Full Text] [Related]
7. Quinaprilat induces arterial vasodilation mediated by nitric oxide in humans.
Haefeli WE; Linder L; Lüscher TF
Hypertension; 1997 Oct; 30(4):912-7. PubMed ID: 9336392
[TBL] [Abstract][Full Text] [Related]
8. Significance of endothelial prostacyclin and nitric oxide in peripheral and pulmonary circulation.
Gryglewski RJ; Chłopicki S; Uracz W; Marcinkiewicz E
Med Sci Monit; 2001; 7(1):1-16. PubMed ID: 11208485
[TBL] [Abstract][Full Text] [Related]
9. Quinapril: a new second-generation ACE inhibitor.
Cetnarowski-Cropp AB
DICP; 1991 May; 25(5):499-504. PubMed ID: 2068835
[TBL] [Abstract][Full Text] [Related]
10. A pharmacodynamic and pharmacokinetic comparison of intravenous quinaprilat and oral quinapril.
Breslin E; Posvar E; Neub M; Trenk D; Jahnchen E
J Clin Pharmacol; 1996 May; 36(5):414-21. PubMed ID: 8739020
[TBL] [Abstract][Full Text] [Related]
11. Comparative pharmacokinetics of captopril, enalapril, and quinapril.
Vertes V; Haynie R
Am J Cardiol; 1992 Apr; 69(10):8C-16C. PubMed ID: 1546641
[TBL] [Abstract][Full Text] [Related]
12. High tissue affinity angiotensin-converting enzyme inhibitors improve endothelial function and reduce infarct size.
Lazar HL; Bao Y; Rivers S; Colton T; Bernard SA
Ann Thorac Surg; 2001 Aug; 72(2):548-53; discussion 553-4. PubMed ID: 11515896
[TBL] [Abstract][Full Text] [Related]
13. Quinaprilat-induced vasodilatation in forearm vasculature of patients with essential hypertension: comparison with enalaprilat.
Houben AJ; Kroon AA; de Haan CH; Fuss-Lejeune MJ; de Leeuw PW
Cardiovasc Drugs Ther; 2000 Dec; 14(6):657-63. PubMed ID: 11300367
[TBL] [Abstract][Full Text] [Related]
14. Effect of enalapril and quinapril on forearm vascular ACE in man.
Lyons D; Webster J; Benjamin N
Eur J Clin Pharmacol; 1997; 51(5):373-8. PubMed ID: 9049577
[TBL] [Abstract][Full Text] [Related]
15. Compared properties of trandolapril, enalapril, and their diacid metabolites.
Chevillard C; Jouquey S; Bree F; Mathieu MN; Stepniewski JP; Tillement JP; Hamon G; Corvol P
J Cardiovasc Pharmacol; 1994; 23 Suppl 4():S11-5. PubMed ID: 7527095
[TBL] [Abstract][Full Text] [Related]
16. Quinapril. A reappraisal of its pharmacology and therapeutic efficacy in cardiovascular disorders.
Plosker GL; Sorkin EM
Drugs; 1994 Aug; 48(2):227-52. PubMed ID: 7527326
[TBL] [Abstract][Full Text] [Related]
17. Protective action of angiotensin converting enzyme inhibitors on cardiac hypertrophy in the aortic-banded rat.
Kurosawa Y; Kojima K; Kato M; Ohashi R; Minami K; Narita H
Jpn Heart J; 1999 Sep; 40(5):645-54. PubMed ID: 10888384
[TBL] [Abstract][Full Text] [Related]
18. The pharmacokinetics and pharmacodynamics of quinapril and quinaprilat in renal impairment.
Begg EJ; Robson RA; Bailey RR; Lynn KL; Frank GJ; Olson SC
Br J Clin Pharmacol; 1990 Aug; 30(2):213-20. PubMed ID: 2144994
[TBL] [Abstract][Full Text] [Related]
19. Captopril and quinapril reduce reactive oxygen species.
van der Giet M; Erinola M; Zidek W; Tepel M
Eur J Clin Invest; 2002 Oct; 32(10):732-7. PubMed ID: 12406020
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of quinaprilat and enalaprilat on endothelial function of conduit arteries in patients with chronic heart failure.
Hornig B; Arakawa N; Haussmann D; Drexler H
Circulation; 1998 Dec 22-29; 98(25):2842-8. PubMed ID: 9860785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
